Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.30% is 80% below its 5-year average of 21.45%, near the low end of its 5-year range (4.30%–27.93%).
68.50% below its 12-month average of 13.65%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
4.30%
RETURN ON ASSETS (ROA) AVG TTM
13.65%
RETURN ON ASSETS (ROA) AVG 3Y
19.24%
RETURN ON ASSETS (ROA) AVG 5Y
21.45%
RETURN ON ASSETS (ROA) AVG 10Y
21.32%
RETURN ON ASSETS (ROA) AVG 15Y
18.62%
RETURN ON ASSETS (ROA) AVG 20Y
16.79%
CURRENT VS TTM AVG
-68.50%
CURRENT VS 3Y AVG
-77.66%
CURRENT VS 5Y AVG
-79.95%
CURRENT VS 10Y AVG
-79.83%
CURRENT VS 15Y AVG
-76.91%
CURRENT VS 20Y AVG
-74.39%
SECTOR MEDIAN · HEALTHCARE
4.94%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-12.96%
vs the sector median at left
NRC Health
Market Cap
$464.48M
Return on Assets (ROA)
4.30%
TTM Avg
13.65%
3Y Avg
19.24%
5Y Avg
21.45%
Market Cap
$401.08M
Return on Assets (ROA)
-23.05%
TTM Avg
-30.00%
3Y Avg
-27.77%
5Y Avg
-27.77%
Market Cap
$1.22B
Return on Assets (ROA)
-6.43%
TTM Avg
-17.46%
3Y Avg
-82.63%
5Y Avg
-55.94%
Market Cap
$2.29B
Return on Assets (ROA)
-10.49%
TTM Avg
-13.41%
3Y Avg
-10.26%
5Y Avg
-6.23%
Market Cap
$3.01B
Return on Assets (ROA)
10.36%
TTM Avg
11.11%
3Y Avg
1.40%
5Y Avg
-7.68%
Market Cap
$6.69B
Return on Assets (ROA)
-3.91%
TTM Avg
11.88%
3Y Avg
0.12%
5Y Avg
-6.73%
Market Cap
$7.68B
Return on Assets (ROA)
4.91%
TTM Avg
-3.24%
3Y Avg
-6.85%
5Y Avg
-10.42%
Market Cap
$9.57B
Return on Assets (ROA)
-10.75%
TTM Avg
-43.49%
3Y Avg
-42.71%
5Y Avg
-41.26%
Market Cap
$9.75B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NRC Health (NRC) | $464.48M | 4.30% | 13.65% | 19.24% | 21.45% |
| Shoulder Innovations, Inc. (SI)vs › | $401.08M | -23.05% | -30.00% | -27.77% | -27.77% |
| Teladoc Health, Inc. (TDOC)vs › | $1.22B | -6.43% | -17.46% | -82.63% | -55.94% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.29B | -10.49% | -13.41% | -10.26% | -6.23% |
| TransMedics Group, Inc. (TMDX)vs › | $3.01B | 10.36% | 11.11% | 1.40% | -7.68% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.69B | -3.91% | 11.88% | 0.12% | -6.73% |
| Oscar Health, Inc. (OSCR)vs › | $7.68B | 4.91% | -3.24% | -6.85% | -10.42% |
| Tempus AI, Inc. (TEM)vs › | $9.57B | -10.75% | -43.49% | -42.71% | -41.26% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.75B | 2.17% | -6.26% | -11.14% | 1.46% |
| Insulet Corp. (PODD)vs › | $10.05B | 11.86% | 10.65% | 7.37% | 5.11% |
ROA
4.3%
ROE
89.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 8.60% |
| 2024-12-31 | 18.70% |
| 2023-12-31 | 25.30% |
| 2022-12-31 | 24.38% |
| 2021-12-31 | 23.78% |
| 2020-12-31 | 27.93% |
| 2019-12-31 | 29.28% |
| 2018-12-31 | 27.90% |
| 2017-12-31 | 18.02% |
| 2016-12-31 | 17.01% |
| 2015-12-31 | 13.64% |
| 2014-12-31 | 14.02% |
| 2013-12-31 | 13.95% |
| 2012-12-31 | 15.06% |
| 2011-12-31 | 11.49% |
| 2010-12-31 | 8.89% |
| 2009-12-31 | 11.71% |
| 2008-12-31 | 10.54% |
| 2007-12-31 | 11.05% |
| 2006-12-31 | 9.56% |
| 2005-12-31 | 11.72% |
| 2004-12-31 | 9.49% |
| 2003-12-31 | 9.60% |
| 2002-12-31 | 9.91% |
| 2001-12-31 | 4.95% |
| 2000-12-31 | 8.59% |
| 1999-12-31 | 5.12% |
| 1998-12-31 | 1.90% |
| 1997-12-31 | 14.16% |
| 1996-12-31 | 37.10% |
